Home / Inspections / 625271

FDA Inspection 625271 — KBI Biopharma, Inc.

KBI Biopharma, Inc. — FEI 3004638264

The FDA completed an inspection of KBI Biopharma, Inc. on October 9, 2009 in Durham, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 9, 2009
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Durham, NC (United States)

Facility

Other inspections at this facility

  • 1312108 (VAI Wed Apr 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1051652 (NAI Wed Apr 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 937768 (NAI Thu Jul 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 796226 (NAI Wed Aug 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources